3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Xanthogranuloma, Juvenile
1
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neurofibrosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Nerve Sheath Neoplasms
1
Medulloblastoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Inhibition, Psychological
1
Histiocytosis, Langerhans-Cell
1
Histiocytic Sarcoma
1
Hepatoblastoma
1
Glioma
1
Ependymoma
1
Central Nervous System Neoplasms
1
Carcinoma, Transitional Cell
1
Interventions
Nivolumab
25
Specimen Handling
19
cabozantinib
15
Magnetic Resonance Spectroscopy
13
Ipilimumab
13
pembrolizumab
11
belzutifan
10
CTLA-4 Antigen
7
Biopsy
7
Axitinib
7
lenvatinib
5
atezolizumab
4
Sunitinib
4
tivozanib
3
Surveys and Questionnaires
3
Immunoglobulin G
3
Everolimus
3
Disulfides
3
zimberelimab
2
relatlimab
2
pazopanib
2
palbociclib
2
aldesleukin
2
X-Rays
2
Watchful Waiting
2
Radiosurgery
2
Nephrectomy
2
Bevacizumab
2
ulixertinib
1
trastuzumab deruxtecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
tazemetostat
×
30 days
×
Clear all
No trials found.